Zinc Citrate

Category
mineral
Routes
Oral (PO)
Half-Life (t½)
PO: 4h
Formula
C12H10O14Zn3
Molecular Weight
574.34 g/mol
PubChem CID
11023

Pharmacological Mechanism

Zinc chelated to citrate. Bioavailability comparable to zinc gluconate (~20–25%); preferred form in some lozenge formulations for upper respiratory infections. ~31% elemental Zn by weight.

Half-Life & Elimination Curve (PO: 4h)

100%50%25%12.5%0%0h0×t½4h1×t½8h2×t½12h3×t½16h4×t½20h5×t½0×t½ (0h): 100% remaining (~46 µg/L)1×t½ (4h): 50% remaining (~23 µg/L)2×t½ (8h): 25% remaining (~11.5 µg/L)3×t½ (12h): 12.5% remaining (~5.76 µg/L)4×t½ (16h): 6.3% remaining (~2.88 µg/L)5×t½ (20h): 3.1% remaining (~1.44 µg/L)
Plasma (PO)t½ Decay (4h)
  • 0×t½0h100% (46 µg/L)
  • 1×t½4h50% (23 µg/L)
  • 2×t½8h25% (11.5 µg/L)
  • 3×t½12h12.5% (5.76 µg/L)
  • 4×t½16h6.3% (2.88 µg/L)
  • 5×t½20h3.1% (1.44 µg/L)
Elimination t½4h (PO)
Rate Constant (ke)0.173 h⁻¹
Time to Peak (Tmax)2.91h
Est. Peak (Cmax)46 µg/L
Clearance (CL)34.7 L/h
97% Washout (5×t½)20h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References